Published on in Vol 27 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/73983, first published .
Correction: Mortality Risk Prediction in Patients With Antimelanoma Differentiation–Associated, Gene 5 Antibody–Positive, Dermatomyositis–Associated Interstitial Lung Disease: Algorithm Development and Validation

Correction: Mortality Risk Prediction in Patients With Antimelanoma Differentiation–Associated, Gene 5 Antibody–Positive, Dermatomyositis–Associated Interstitial Lung Disease: Algorithm Development and Validation

Correction: Mortality Risk Prediction in Patients With Antimelanoma Differentiation–Associated, Gene 5 Antibody–Positive, Dermatomyositis–Associated Interstitial Lung Disease: Algorithm Development and Validation

Corrigenda and Addenda

1Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China

2Department of Pulmonary and Critical Care Medicine, Seventh Affiliated Hospital, Sun Yatsen University, Shenzhen, China

3Department of Pulmonary and Critical Care Medicine, General Hospital of Ningxia Medical University, Yinchuan, China

4Department of Respiratory and Critical Care Medicine, Third People’s Hospital of Chengdu, Chengdu, China

5Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China

6National Center for Respiratory Medicine, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China

7China-Japan Friendship Hospital, Key Laboratory of Myositis (Beijing Key Laboratory for Immune Mediated Inflammatory Diseases), Department of Rheumatology, Beijing, China

*these authors contributed equally

Corresponding Author:

Hourong Cai, MD

Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University

321 Zhongshan Rd., Gulou District

Nanjing, 210008

China

Phone: 86 025 83106666

Email: caihourong2013@163.com



In “Mortality Risk Prediction in Patients With Antimelanoma Differentiation–Associated, Gene 5 Antibody–Positive, Dermatomyositis–Associated Interstitial Lung Disease: Algorithm Development and Validation” (J Med Internet Res 2025;27:e62836) the authors made one change.

Affiliation 1 has been changed from:

Department of Respiratory and Critical Care Medicine, Affiliated Drum Tower Hospital, Nanjing University Medical School, Nanjing, China

to:

Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital,Affiliated Hospital of Medical School,Nanjing University,Nanjing, China

The correction will appear in the online version of the paper on the JMIR Publications website, together with the publication of this correction notice. Because this was made after submission to PubMed, PubMed Central, and other full-text repositories, the corrected article has also been resubmitted to those repositories.

This is a non–peer-reviewed article. submitted 19.03.25; accepted 19.03.25; published 07.04.25.

Copyright

©Hui Li, Ruyi Zou, Hongxia Xin, Ping He, Bin Xi, Yaqiong Tian, Qi Zhao, Xin Yan, Xiaohua Qiu, Yujuan Gao, Yin Liu, Min Cao, Bi Chen, Qian Han, Juan Chen, Guochun Wang, Hourong Cai. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 07.04.2025.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research (ISSN 1438-8871), is properly cited. The complete bibliographic information, a link to the original publication on https://www.jmir.org/, as well as this copyright and license information must be included.